Carnegie Investment Counsel’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.82M | Sell |
33,138
-818
| -2% | -$72.9K | 0.06% | 233 |
|
|
2025
Q4 | $2.68M | Buy |
33,956
+450
| +1% | +$35.3K | 0.05% | 238 |
|
|
2025
Q3 | $2.68M | Sell |
33,506
-200
| -0.6% | -$17.1K | 0.05% | 227 |
|
|
2025
Q2 | $3.06M | Buy |
33,706
+400
| +1% | +$36.5K | 0.06% | 207 |
|
|
2025
Q1 | $3.04M | Buy |
33,306
+14,144
| +74% | +$1.27M | 0.07% | 193 |
|
|
2024
Q4 | $1.74M | Sell |
19,162
-81
| -0.4% | -$7.73K | 0.05% | 218 |
|
|
2024
Q3 | $2M | Sell |
19,243
-500
| -3% | -$51K | 0.06% | 220 |
|
|
2024
Q2 | $1.92M | Sell |
19,743
-1,566
| -7% | -$144K | 0.06% | 212 |
|
|
2024
Q1 | $1.92M | Sell |
21,309
-1
| -0% | -$85 | 0.06% | 218 |
|
|
2023
Q4 | $1.7M | Buy |
21,310
+2,201
| +12% | +$165K | 0.06% | 223 |
|
|
2023
Q3 | $1.36M | Sell |
19,109
-179
| -0.9% | -$13.4K | 0.05% | 232 |
|
|
2023
Q2 | $1.49M | Sell |
19,288
-42
| -0.2% | -$3.25K | 0.06% | 234 |
|
|
2023
Q1 | $1.45M | Sell |
19,330
-262
| -1% | -$19.5K | 0.06% | 240 |
|
|
2022
Q4 | $1.54M | Buy |
19,592
+189
| +1% | +$14.2K | 0.07% | 224 |
|
|
2022
Q3 | $1.36M | Buy |
19,403
+339
| +2% | +$26.6K | 0.07% | 230 |
|
|
2022
Q2 | $1.53M | Buy |
19,064
+61
| +0.3% | +$4.77K | 0.07% | 217 |
|
|
2022
Q1 | $1.44M | Sell |
19,003
-8,057
| -30% | -$638K | 0.05% | 228 |
|
|
2021
Q4 | $2.31M | Buy |
27,060
+652
| +2% | +$50.9K | 0.08% | 191 |
|
|
2021
Q3 | $2M | Buy |
26,408
+2,397
| +10% | +$190K | 0.08% | 182 |
|
|
2021
Q2 | $1.95M | Sell |
24,011
-1,047
| -4% | -$85.6K | 0.07% | 188 |
|
|
2021
Q1 | $1.98M | Buy |
25,058
+787
| +3% | +$61.7K | 0.08% | 185 |
|
|
2020
Q4 | $2.08M | Sell |
24,271
-55
| -0.2% | -$4.55K | 0.09% | 172 |
|
|
2020
Q3 | $1.88M | Sell |
24,326
-2,300
| -9% | -$175K | 0.1% | 164 |
|
|
2020
Q2 | $1.95M | Hold |
26,626
| – | – | 0.11% | 162 |
|
|
2020
Q1 | $1.77M | Sell |
26,626
-896
| -3% | -$63.2K | 0.12% | 158 |
|
|
2019
Q4 | $1.9M | Hold |
27,522
| – | – | 0.11% | 167 |
|
|
2019
Q3 | $2.02M | Sell |
27,522
-84
| -0.3% | -$6.09K | 0.13% | 161 |
|
|
2019
Q2 | $1.98M | Sell |
27,606
-591
| -2% | -$42K | 0.13% | 156 |
|
|
2019
Q1 | $1.93M | Sell |
28,197
-336
| -1% | -$21.7K | 0.13% | 152 |
|
|
2018
Q4 | $1.7M | Sell |
28,533
-27,681
| -49% | -$1.73M | 0.16% | 145 |
|
|
2018
Q3 | $3.56M | Buy |
56,214
+27,250
| +94% | +$1.82M | 0.29% | 99 |
|
|
2018
Q2 | $1.9M | Sell |
28,964
-490
| -2% | -$32.1K | 0.14% | 148 |
|
|
2018
Q1 | $1.85M | Sell |
29,454
-1,149
| -4% | -$82.7K | 0.15% | 140 |
|
|
2017
Q4 | $2.15M | Sell |
30,603
-318
| -1% | -$23.2K | 0.19% | 141 |
|
|
2017
Q3 | $2.23M | Buy |
30,921
+8
| +0% | +$577 | 0.26% | 108 |
|
|
2017
Q2 | $2.21M | Buy |
30,913
+7
| +0% | +$520 | 0.27% | 110 |
|
|
2017
Q1 | $2.22M | Sell |
30,906
-148
| -0.5% | -$10.4K | 0.28% | 105 |
|
|
2016
Q4 | $2.07M | Sell |
31,054
-427
| -1% | -$29.3K | 0.28% | 105 |
|
|
2016
Q3 | $2.27M | Buy |
31,481
+572
| +2% | +$42.3K | 0.33% | 88 |
|
|
2016
Q2 | $2.27M | Buy |
30,909
+506
| +2% | +$36K | 0.32% | 92 |
|
|
2016
Q1 | $2.15M | Sell |
30,403
-346
| -1% | -$23K | 0.33% | 89 |
|
|
2015
Q4 | $2.06M | Buy |
30,749
+4,157
| +16% | +$277K | 0.36% | 82 |
|
|
2015
Q3 | $1.83M | Buy |
26,592
+2,991
| +13% | +$195K | 0.32% | 86 |
|
|
2015
Q2 | $1.54M | Buy |
23,601
+2,600
| +12% | +$176K | 0.27% | 94 |
|
|
2015
Q1 | $1.46M | Buy |
21,001
+15,790
| +303% | +$1.09M | 0.25% | 99 |
|
|
2014
Q4 | $361K | Buy |
5,211
+296
| +6% | +$20K | 0.07% | 210 |
|
|
2014
Q3 | $321K | Buy |
+4,915
| New | +$324K | 0.06% | 224 |
|
Other funds holding CL
VCM
DAM
VPM
Carnegie Investment Counsel's CL Position: Q1 2026 in Review
Carnegie Investment Counsel reduced its Colgate-Palmolive (CL) stake by 2.4% in Q1 2026, selling an estimated $72.9K and leaving 33,138 shares worth $2.82M. The position accounts for 0.06% of the portfolio, ranked #233.
Carnegie Investment Counsel first reported a position in CL in Q3 2014 and has held it in 47 quarters since. The position peaked at $3.56M in Q3 2018. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Carnegie Investment Counsel held 33,138 shares of Colgate-Palmolive worth $2.82M as of Q1 2026.
- Carnegie Investment Counsel sold 818 Colgate-Palmolive shares in Q1 2026, an estimated $72.9K.
- Colgate-Palmolive made up 0.06% of Carnegie Investment Counsel's portfolio in Q1 2026, its #233 holding.
- Carnegie Investment Counsel first reported a position in Colgate-Palmolive in Q3 2014 and has held it in 47 quarters since.
- Carnegie Investment Counsel's Colgate-Palmolive position peaked at $3.56M in Q3 2018.
- 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Carnegie Investment Counsel's 13F filing for Q1 2026, filed 1 May 2026.